Rejuvenating blood-forming stem cells to slow systemic aging

Hematopoietic stem cells (HSCs) in bone marrow lose regenerative capacity with age, driving immunological decline and accelerating systemic aging. A single treatment with CASIN, a small-molecule Cdc42 inhibitor, restored polarized HSC proportion in aged mice, significantly extended lifespan, and reduced systemic inflammatory cytokines—effects that exceed what exercise achieves. Parallel pharmacological approaches show comparable results: nicotinamide riboside (NR) restores metabolic competence in aged HSCs; mTOR inhibition with rapamycin reverses age-related functional decline; and the senolytic ABT263 clears senescent HSCs and partially restores regenerative capacity. Yamanaka factors (Oct4, Sox2, Klf4, c-Myc) demonstrated systemic rejuvenation in murine models, though their specific impact on human HSCs remains under investigation. For the longevity-curious reader, this represents a paradigm shift: where exercise shows minimal HSC rejuvenation, these molecular interventions open a tangible pathway toward genuine immune restoration in advanced aging.